{"title":"Neglected outcomes of cerebrovascular disorders in neuromuscular diseases","authors":"Benedikt Schoser","doi":"10.1111/ene.16569","DOIUrl":null,"url":null,"abstract":"<p>Stroke and multisystemic features are easily overlooked in neuromuscular disorders (NMDs). The scientific literature is limited to this topic, and long-term outcomes are rarely reported. In this issue, Al-Salahat and colleagues report on cerebrovascular diseases (CVDs) outcomes in patients with muscular dystrophies (MD). A 10-year screening in their nationwide readmission database identified hospitalizations for CVDs, including ischemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and other unspecified CVDs.</p><p>They found in 6,129,132 CVD hospitalizations, that 0.03% (2098) were MD patients. Ischemic stroke was the most common type, followed by intracerebral hemorrhage. MD patients had 41% lower odds of routine discharge, 9% greater costs, 30% lower odds of 90-day all-cause readmissions, and a higher in-patient mortality [<span>1</span>]. These results point clearly towards a higher risk of scarce outcomes of CVD in MD patients. This emphasizes a high need for boosted access to amended post-discharge care, like stroke rehabilitation for people living with MD.</p><p>Therefore, the authors presented an essential work for the overall health of neuromuscular patients. To widen the scope of this report, considering stroke sequelae and outcomes in Duchenne muscular dystrophy, the most frequent x-linked MD in young adults, one report, covering a total observation period of 400 patient-years, identified four DMD with juvenile arterial ischemic strokes. Systemic thrombolysis in two patients resulted in a regression of stroke symptoms, but one patient died of septic pneumonia and cardiac failure 24 days after thrombolysis. Both other patients persisted with severe infarction-related symptoms, with an early death in one of them. DMD-associated cardiomyopathy without evidence of atrial fibrillation was the only risk factor for ischemic stroke in all patients [<span>2</span>].</p><p>Looking at metabolic lysosomal neuromuscular disorders, Fabry disease has an esteemed birth prevalence ranging from 1 in 476,000 to 1 in 117,000. However, for stroke neurologists, recognizing the X-linked lysosomal storage disorder of glycosphingolipid metabolism is still challenging. According to FD registry data, up to 15% of patients may experience a stroke [<span>3</span>]. Cerebrovascular manifestations of FD may include thrombosis, transient ischemic attacks, basilar artery ischemia and aneurysm, seizures, hemiplegia, hemianesthesia, aphasia, labyrinthine disorders, or cerebral hemorrhage. Individuals living with FD may have increased basilar artery mean diameter and linear length compared with controls. White matter lesions are frequently found on brain MRIs of FD; age and prior stroke independently predicted the burden of white matter hyperintensities [<span>3</span>]. Similarly, in another lysosomal storage disorder, Pompe disease, stroke-related sequelae of megadolichobasliaris, stroke, and subarachnoidal hemorrhage can occur [<span>4-6</span>].</p><p>Finally, stroke-like episodes as paroxysmal neurological sequelae may be part of specific mitochondrial diseases. It is essential to differentiate stroke-like episodes from cerebral infarction or intracerebral hemorrhage, mainly due to the variety in management. Focal-onset seizures, encephalopathy, and visual disturbances are prominent findings associated with stroke-like episodes, with a preference for the posterior cerebral cortex resulting in progressive brain atrophy and dementia. The most common cause of stroke-like episodes is the m.3243A > G variant in MT-TL1 gene, resulting in mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS). Seizure management is warranted [<span>7, 8</span>].</p><p>In conclusion, stroke and other cerebrovascular disorders in younger patients should alert stroke neurologists to search and screen for a genetic (neuromuscular) background. For improvement of the overall stroke prognosis in NMDs, personalized care needs to be better defined.</p><p><b>Benedikt Schoser:</b> Conceptualization; writing – review and editing; data curation; project administration; validation; writing – original draft; investigation; formal analysis; supervision; resources.</p><p>The author reports no conflict of interest.</p>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":"32 1","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625925/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ene.16569","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Stroke and multisystemic features are easily overlooked in neuromuscular disorders (NMDs). The scientific literature is limited to this topic, and long-term outcomes are rarely reported. In this issue, Al-Salahat and colleagues report on cerebrovascular diseases (CVDs) outcomes in patients with muscular dystrophies (MD). A 10-year screening in their nationwide readmission database identified hospitalizations for CVDs, including ischemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and other unspecified CVDs.
They found in 6,129,132 CVD hospitalizations, that 0.03% (2098) were MD patients. Ischemic stroke was the most common type, followed by intracerebral hemorrhage. MD patients had 41% lower odds of routine discharge, 9% greater costs, 30% lower odds of 90-day all-cause readmissions, and a higher in-patient mortality [1]. These results point clearly towards a higher risk of scarce outcomes of CVD in MD patients. This emphasizes a high need for boosted access to amended post-discharge care, like stroke rehabilitation for people living with MD.
Therefore, the authors presented an essential work for the overall health of neuromuscular patients. To widen the scope of this report, considering stroke sequelae and outcomes in Duchenne muscular dystrophy, the most frequent x-linked MD in young adults, one report, covering a total observation period of 400 patient-years, identified four DMD with juvenile arterial ischemic strokes. Systemic thrombolysis in two patients resulted in a regression of stroke symptoms, but one patient died of septic pneumonia and cardiac failure 24 days after thrombolysis. Both other patients persisted with severe infarction-related symptoms, with an early death in one of them. DMD-associated cardiomyopathy without evidence of atrial fibrillation was the only risk factor for ischemic stroke in all patients [2].
Looking at metabolic lysosomal neuromuscular disorders, Fabry disease has an esteemed birth prevalence ranging from 1 in 476,000 to 1 in 117,000. However, for stroke neurologists, recognizing the X-linked lysosomal storage disorder of glycosphingolipid metabolism is still challenging. According to FD registry data, up to 15% of patients may experience a stroke [3]. Cerebrovascular manifestations of FD may include thrombosis, transient ischemic attacks, basilar artery ischemia and aneurysm, seizures, hemiplegia, hemianesthesia, aphasia, labyrinthine disorders, or cerebral hemorrhage. Individuals living with FD may have increased basilar artery mean diameter and linear length compared with controls. White matter lesions are frequently found on brain MRIs of FD; age and prior stroke independently predicted the burden of white matter hyperintensities [3]. Similarly, in another lysosomal storage disorder, Pompe disease, stroke-related sequelae of megadolichobasliaris, stroke, and subarachnoidal hemorrhage can occur [4-6].
Finally, stroke-like episodes as paroxysmal neurological sequelae may be part of specific mitochondrial diseases. It is essential to differentiate stroke-like episodes from cerebral infarction or intracerebral hemorrhage, mainly due to the variety in management. Focal-onset seizures, encephalopathy, and visual disturbances are prominent findings associated with stroke-like episodes, with a preference for the posterior cerebral cortex resulting in progressive brain atrophy and dementia. The most common cause of stroke-like episodes is the m.3243A > G variant in MT-TL1 gene, resulting in mitochondrial myopathy, encephalopathy, lactacidosis, and stroke (MELAS). Seizure management is warranted [7, 8].
In conclusion, stroke and other cerebrovascular disorders in younger patients should alert stroke neurologists to search and screen for a genetic (neuromuscular) background. For improvement of the overall stroke prognosis in NMDs, personalized care needs to be better defined.
Benedikt Schoser: Conceptualization; writing – review and editing; data curation; project administration; validation; writing – original draft; investigation; formal analysis; supervision; resources.
期刊介绍:
The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).